Literature DB >> 7667279

Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.

J D Smith1, E Trogan, M Ginsberg, C Grigaux, J Tian, M Miyata.   

Abstract

To develop a murine model system to test the role of monocyte-derived macrophage in atherosclerosis, the osteopetrotic (op) mutation in the macrophage colony-stimulating factor gene was bred onto the apolipoprotein E (apoE)-deficient background. The doubly mutant (op/apoE-deficient) mice fed a low-fat chow diet had significantly smaller proximal aortic lesions at an earlier stage of progression than their apoE-deficient control littermates. These lesions in the doubly mutant mice were composed of macrophage foam cells. The op/apoE-deficient mice also had decreased body weights, decreased blood monocyte differentials, and increased mean cholesterol levels of approximately 1300 mg/dl. Statistical analysis determined that atherosclerosis lesion area was significantly affected by the op genotype and gender. The confounding variables of body weight, plasma cholesterol, and monocyte differential, which were all affected by op genotype, had no significant additional effect on lesion area once they were adjusted for the effects of op genotype and gender. Unexpectedly, there was a significant inverse correlation between plasma cholesterol and lesion area, implying that each may be the result of a common effect of macrophage colony-stimulating factor levels. The data support the hypothesis that macrophage colony-stimulating factor and its effects on macrophage development and function play a key role in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7667279      PMCID: PMC41137          DOI: 10.1073/pnas.92.18.8264

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Effects of recombinant human macrophage colony-stimulating factor on plasma cholesterol levels.

Authors:  J B Stoudemire; M B Garnick
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

2.  Serum cholesterol-lowering activity of human monocytic colony-stimulating factor.

Authors:  K Motoyoshi; F Takaku
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

3.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.

Authors:  W Wiktor-Jedrzejczak; A Bartocci; A W Ferrante; A Ahmed-Ansari; K W Sell; J W Pollard; E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes.

Authors:  S K Basu; Y K Ho; M S Brown; D W Bilheimer; R G Anderson; J L Goldstein
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

5.  Monocyte colony-stimulating factor enhances uptake and degradation of acetylated low density lipoproteins and cholesterol esterification in human monocyte-derived macrophages.

Authors:  S Ishibashi; T Inaba; H Shimano; K Harada; I Inoue; H Mokuno; N Mori; T Gotoda; F Takaku; N Yamada
Journal:  J Biol Chem       Date:  1990-08-25       Impact factor: 5.157

6.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene.

Authors:  H Yoshida; S Hayashi; T Kunisada; M Ogawa; S Nishikawa; H Okamura; T Sudo; L D Shultz; S Nishikawa
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

7.  Colony stimulating factor 1 is required for mammary gland development during pregnancy.

Authors:  J W Pollard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification.

Authors:  J H Qiao; P Z Xie; M C Fishbein; J Kreuzer; T A Drake; L L Demer; A J Lusis
Journal:  Arterioscler Thromb       Date:  1994-09

9.  Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor.

Authors:  H Kodama; A Yamasaki; M Nose; S Niida; Y Ohgame; M Abe; M Kumegawa; T Suda
Journal:  J Exp Med       Date:  1991-01-01       Impact factor: 14.307

10.  Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse.

Authors:  M G Cecchini; M G Dominguez; S Mocci; A Wetterwald; R Felix; H Fleisch; O Chisholm; W Hofstetter; J W Pollard; E R Stanley
Journal:  Development       Date:  1994-06       Impact factor: 6.868

View more
  181 in total

Review 1.  Did the antioxidant trials fail to validate the oxidation hypothesis?

Authors:  S Parthasarathy; N Khan-Merchant; M Penumetcha; B V Khan; N Santanam
Journal:  Curr Atheroscler Rep       Date:  2001-09       Impact factor: 5.113

2.  Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor.

Authors:  T Herembert; J Gogusev; D L Zhu; T B Drueke; P Marche
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.

Authors:  J H Qiao; J Tripathi; N K Mishra; Y Cai; S Tripathi; X P Wang; S Imes; M C Fishbein; S K Clinton; P Libby; A J Lusis; T B Rajavashisth
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

4.  Coronary artery disease, inflammation and the ghost of John Hunter.

Authors:  Ernest L Fallen
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

5.  Macrophage accumulation in atherosclerosis.

Authors:  Brian W Parks; Aldons J Lusis
Journal:  N Engl J Med       Date:  2013-12-12       Impact factor: 91.245

6.  Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma.

Authors:  L Chastine Bell-Parikh; Tomomi Ide; John A Lawson; Peter McNamara; Muredach Reilly; Garret A FitzGerald
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  p21Cip1 is required for the development of monocytes and their response to serum transfer-induced arthritis.

Authors:  John C Scatizzi; Jack Hutcheson; Emily Bickel; James M Woods; Karolina Klosowska; Terry L Moore; G Kenneth Haines; Harris Perlman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 8.  Regulation of an inflammatory disease: Krüppel-like factors and atherosclerosis.

Authors:  Mukesh K Jain; Panjamaporn Sangwung; Anne Hamik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

9.  Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis.

Authors:  Hua Qing; Yi Liu; Yue Zhao; Jun Aono; Karrie L Jones; Elizabeth B Heywood; Deborah Howatt; Cassi M Binkley; Alan Daugherty; Ying Liang; Dennis Bruemmer
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

Review 10.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.